Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 269 papers

Pro-resolving actions of SPM in adipose tissue biology

Clària J, López-Vicario C, Rius B, Titos E.

Mol Aspects Med 2017, 58: 83–92

DOI: 10.1016/j.mam.2017.03.004

Mouse and rat models of induction of hepatic fibrosis and assessment of portal hypertension

Klein S, Schierwagen R, Uschner FE, Trebicka J.

Methods Mol Biol 2017, 1627: 91–116. In Fibrosis: Methods and Protocols. Rittié L, Ed. Springer Protocols, Humana New York, NY, 22 August 2027.

DOI: 10.1007/978-1-4939-7113-8_7

Sepsis in alcohol-related liver disease

Gustot T, Fernandez J, Szabo G, Albillos A, Louvet A, Jalan R, Moreau R, Moreno C.

J Hepatol 2017, 67(5): 1031–1050

DOI: 10.1016/j.jhep.2017.06.013

Selected patients with acute-on-chronic liver failure grade 3 are not too sick to be considered for liver transplantation

Gustot T, Agarwal B.

J Hepatol 2017, 67(4): 667–668

DOI: 10.1016/j.jhep.2017.07.017

Molecular adsorbent recirculating system can reduce short-term mortality among patients with acute-on-chronic liver failure — A retrospective analysis

Gerth HU, Pohlen M, Thölking G, Pavenstädt H, Brand M, Hüsing-Kabar A, Wilms C, Maschmeier M, Kabar I, Torner J, Pavesi M, Arroyo V, Banares R, Schmidt HHJ.

Crit Care Med 2017, 45(10): 1616—1624

DOI: 10.1097/CCM.0000000000002562

Plasma cystatin C is a predictor of renal dysfunction, acute‐on‐chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis

Markwardt D, Holdt L, Steib C, Benesic A, Bendtsen F, Bernardi M, Moreau R, Teupser D, Wendon J, Nevens F, Trebicka J, Garcia E, Pavesi M, Arroyo V, Gerbes AL.

Hepatology 2017, 66(4): 1232—1241

DOI: 10.1002/hep.29290

Microalbuminuria, systemic inflammation, and multiorgan dysfunction in decompensated cirrhosis: Evidence for a nonfunctional mechanism of hepatorenal syndrome

Arroyo V.

Hepatol Int 2017, 11(3): 242—244

DOI: 10.1007/s12072-017-9784-3

Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis

Kerbert AJ, Schaapman JJ, van der Reijden JJ, Amorós Navarro À, McCormick A, van Hoek B, Arroyo V, Ginès P, Jalan R, Vargas V, Stauber R, Verspaget HW, Coenraad MJ; CANONIC Study Investigators of the EASL-CLIF Consortium.

Eur J Gastroenterol Hepatol, 29(5): 535—538

DOI: 10.1097/MEG.0000000000000834

Portal vein thrombosis in patients with cirrhosis

von Köckritz L, De Gottardi A, Trebicka J, Praktiknjo M.

Gastroenterol Rep (Oxf) 2017, 5(2): 148–156

DOI: 10.1093/gastro/gox014

Rationale for the use of statins in liver disease

Schierwagen R, Uschner FE, Magdaleno F, Klein S, Trebicka J.

Am J Physiol Gastrointest Liver Physiol 2017, 312(5): G407–G412

DOI: 10.1152/ajpgi.00441.2016